Trexquant Investment LP Amarin Corp Plcuk Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.26 - $6.5 $56,981 - $86,944	-13,376 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.03 - $8.8 $67,281 - $117,708	13,376 New	13,376 $83,000
Q3 2020 Nov 06, 2020	SELL	$3.64 - $7.76 $175,069 - $373,224	-48,096 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$4.78 - $8.26 $1.39 Million - $2.4 Million	-290,380 Reduced 85.79%	48,096 $333,000
Q1 2020 May 08, 2020	BUY	$4.0 - $21.53 $784,480 - $4.22 Million	196,120 Added 137.77%	338,476 $1.35 Million
Q4 2019 Feb 12, 2020	BUY	$13.94 - $24.12 $1.98 Million - $3.43 Million	142,356 New	142,356 $3.05 Million
Q1 2019 May 13, 2019	SELL	$12.61 - $22.33 $2.58 Million - $4.57 Million	-204,627 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $2.27 Million - $4.2 Million	182,594 Added 828.73%	204,627 $2.79 Million
Q3 2018 Nov 09, 2018	BUY	$2.45 - $16.27 $53,980 - $358,476	22,033 New	22,033 $358,000

184

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.